Report Categories
View AllRecent Articles
View All
NATO Defense Spending Surge Anticipated Trump Commits 5000 Troops to Poland
UK Bank Holiday Travel Surge and Warm Weather May Boost Consumer Spending
Global Leaders Watch Closely as TrumpXi Summit Approaches From Singapore to Brussels
Microns 726 Rally An Options Strategy for Potential Pullbacks
Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project
Meta to Test AI Subscription Services Starting at 799 Per Month
BlackRock BLK Q1 2026 Earnings EPS Beat Drives Modest Stock Gain
INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline
Dyne Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Drives Slight Stock Uptick
AERT Q1 2026 Earnings EPS Breaks into Positive Territory Stock Rallies
Essent Group Ltd Q1 2026 Earnings Strong EPS Beat of 604 Surprise Stock Declines
Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure
LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1010 as SPAC Unit Trades in Tight Range
EZGO Technologies Slumps 68 as Shares Approach Critical Support Level
Profound Medical PROF Edges Higher Amid Continued Trade Volume and Technical Firmness
abrdn Global Premier Properties Fund AWP Edges Higher Amid Steady Support Levels
AppFolio APPF Posts 229 Gain as Shares Test Resistance Near 174
External Links
Chancellor Rachel Reeves Moves to Secure Position Amid Potential Labour Leadership Change
Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins
Transocean Ltd RIG Edges Higher Amidst Consolidation Key Resistance at 655 in Focus
MITTC TPG reports quarterly results as preferred dividend policy remains stable amid shifting rate environment
ExxonMobil XOM Oil Majors Warn of Accelerating Global Supply Deficit Amid Geopolitical Disruptions
T3 Defense DFNS Stock Most Active Market Focus 20260418
VTVT vTv Therapeutics Inc narrower than expected Q4 2025 loss pushes shares 373 higher on upbeat investor sentiment
Theriva Biologics TOVX Comprehensive Review Theriva Biologics posts 346 EPS beat no revenue
Fulton FULT Industry Headwinds Q4 2025 EPS Exceeds Expectations
How ArcBest ARCB stacks up against the best in its class Momentum Fading 20260508